CCL2 and neoplasm: illustrated that in mouse pancreatic tumor cells, apigenin(API: a CK2 inhibitor) could suppress the production of tumor-derived factors (TDF), including GM-CSF、IL-6、IFN-γ and MCP-1 to modulate immune cells development and promote tumor regression through enhancing the SHIP-1 expression (69).